Diabetes Associated Ophthalmic Treatment Market size is expected to reach USD 44.7 billion by 2028
Diabetes Associated Ophthalmic Treatment Industry Overview The global diabetes associated ophthalmic treatment market size is expected to reach USD 44.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The increasing prevalence of type II diabetes, geriatric population, and availability of early detection techniques are some of the factors driving the growth. This is coupled with technological advancements and increasing awareness of early diagnostics to help increase the success rate of the available treatment options. An increasing number of clinical trials to assess new drugs and devices for the prevention and management of these ophthalmic conditions are expected to fuel market growth in upcoming years. Diabetes Associated Ophthalmic Treatment Market Segmentation Grand View Research has segmented the global diabetes associated ophthalmic treatment mark...